Top compounds associated with response to LRFN2


Feature Type Standardized
Nominal ANOVA
mRNA nelarabine CTRPv2 pan-cancer AAC 0.12 0.002
mRNA Erlotinib gCSI pan-cancer AAC -0.18 0.002
mRNA BIX-01294 CTRPv2 pan-cancer AAC 0.1 0.002
mRNA bendamustine CTRPv2 pan-cancer AAC 0.11 0.003
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.003
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.003
mRNA pifithrin-mu CTRPv2 pan-cancer AAC 0.1 0.003
mRNA CCT036477 CTRPv2 pan-cancer AAC 0.1 0.003
mRNA GSK690693 GDSC1000 pan-cancer AAC 0.099 0.003
mRNA Docetaxel gCSI pan-cancer AAC -0.16 0.003
Download CSV